General Information
Metabolic Solutions DM 2 C004
A Phase 2B, Randomized, Double-Blind, Comparator-and Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of (study drug) in Type 2 Diabetic Patients.
| Protocol | MSDC-C004 |
|---|---|
| Identifier | MSDC-C004 |
| UID | e41f7925-a160-492a-8c6b-b1c33f9e9b19 |
| Status | Done - Archived |
| Phase | 2B |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2011 |
| NCT Number | - |
| Created | 2011-01-03 18:33 |
| Last Updated | 2011-01-03 18:33 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2011-06-10 | No |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2011-01-26 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2012-02-02 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Metabolic Solutions |
|---|---|
| Division | Metabolic Solutions |
| Team | Metabolic Solutions |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Medpace, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
